Ngôn ngữ / Language:
Đăng nhập Đăng ký Hội viên
Hoi Tim mach hoc Viet Nam
   
 
 
Tin tức
Tin Hoạt động
Liên kết qua Internet
Tin tiếng Anh
MedScape Cardiology
TheHeart.org
InCirculation.Net
EuroPCR & AsiaPCR
TCTMd Conference
European Society of Cardiology
 
Trang chủ / Liên kết qua Internet  Print     Email
Liên kết qua Internet
Các Hội Tim mạch và Y khoa (6/23/2010)
Liên kết tới các Hội Tim mạch và Y khoa khác trên Internet ... Chi tiết
Tạp chí Tim mạch và Y học Trực tuyến (6/23/2010)
Liên kết tới các Tạp chí Tim mạch và Y học Trực tuyến qua Internet ... Chi tiết

MedScape Cardiology
Complete Revascularization in P-PCI: Dramatic Drop in MACE (Mon, 1 Sep 2014 08:39:27 EDT)
Results from the CVLPRIT trial support a strategy of revascularizing all significant lesions at the time of primary PCI, rather than focusing on the infarct-related lesion. But questions remain.
Heartwire
SIGNIFY: No Ivabradine Clinical Outcomes Gain in Stable CAD (Sun, 31 Aug 2014 10:30:35 EDT)
UPDATED // As the drug's main effect is to lower heart rate, the randomized, placebo-controlled trial questions HR as a treatment target in stable CAD patients without heart failure, researchers say.
Heartwire
Huge Decreases in LDL Cholesterol With Alirocumab: ODYSSEY (Sun, 31 Aug 2014 08:37:38 EDT)
Tested in high-risk CVD patients, heterozygous-FH patients, and patients intolerant to statins, treatment with alirocumab resulted in as large as a 60% reduction in LDL cholesterol from baseline. Some patients even got down to LDLs of 50 mg/dL.
Heartwire
PARADIGM-HF: New Drug Class Outclasses ACE-I in Chronic HF (Sat, 30 Aug 2014 06:59:56 EDT)
Although observers are cautious, one expert writes hopefully that the trial "may well represent a new threshold of hope for patients with heart failure."
Heartwire
Analysis Decries BB Stance in Noncardiac-Surgery Guidelines (Fri, 29 Aug 2014 11:46:30 EDT)
UPDATED // In a new analysis, long-time critics of the DECREASE trials argue that these discredited data have still found their way into AHA/ACC and ESC guidelines on noncardiac surgery.
Heartwire
TheHeart.org
Complete Revascularization in P-PCI: Dramatic Drop in MACE (Mon, 1 Sep 2014 08:39:27 EDT)
Results from the CVLPRIT trial support a strategy of revascularizing all significant lesions at the time of primary PCI, rather than focusing on the infarct-related lesion. But questions remain. ...

For complete story visit theheart.org.
SIGNIFY: No Ivabradine Clinical Outcomes Gain in Stable CAD (Sun, 31 Aug 2014 10:30:35 EDT)
UPDATED // As the drug's main effect is to lower heart rate, the randomized, placebo-controlled trial questions HR as a treatment target in stable CAD patients without heart failure, researchers...

For complete story visit theheart.org.
Huge Decreases in LDL Cholesterol With Alirocumab: ODYSSEY (Sun, 31 Aug 2014 08:37:38 EDT)
Tested in high-risk CVD patients, heterozygous-FH patients, and patients intolerant to statins, treatment with alirocumab resulted in as large as a 60% reduction in LDL cholesterol from baseline....

For complete story visit theheart.org.
PARADIGM-HF: New Drug Class Outclasses ACE-I in Chronic HF (Sat, 30 Aug 2014 06:59:56 EDT)
Although observers are cautious, one expert writes hopefully that the trial "may well represent a new threshold of hope for patients with heart failure." Heartwire

For complete story visit theheart.org.
Analysis Decries BB Stance in Noncardiac-Surgery Guidelines (Fri, 29 Aug 2014 11:46:30 EDT)
UPDATED // In a new analysis, long-time critics of the DECREASE trials argue that these discredited data have still found their way into AHA/ACC and ESC guidelines on noncardiac surgery. ...

For complete story visit theheart.org.